Cancer Family
Malignant Genitourinary System Neoplasm
CI-CAN-00000233Explore in graph →
3,549 active trials61 approved drugs295 evidence items
- NCIt
- C156484
Loading cancer entity…
Loading cancer entity…
Cancer Family
CI-CAN-00000233Explore in graph →
Clinical trials
15,544 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancersTerminated studies (1,963)
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT04543110 | Radiation and Durvalumab Immunotherapy As Neoadjuvant Treatment for MIBC(RADIANT) | unknown | Phase 2 | 16 | Ottawa Hospital Research InstituteOTHER | 1 | Mar 23, 2023 | clinicaltrials |
| NCT04060589 | ReIMAGINE Prostate Cancer Risk | unknown | — | 1,000 | University College, LondonOTHER | 1 | Mar 22, 2023 | clinicaltrials |
| NCT05620355 | Efficacy and Safety of BG2109 in Subjects With Heavy Menstrual Bleeding Associated With Uterine Fibroids. | unknown | Phase 3 | 312 | Bio Genuine (Shanghai) Biotech Co., Ltd.INDUSTRY | 1 | Mar 21, 2023 | clinicaltrials |
| NCT05633342 | Project CADENCE (CAncer Detected Early caN be CurEd)(CADENCE) | unknown | — | 15,000 | MiRXES Pte LtdINDUSTRY | 1 | Mar 20, 2023 | clinicaltrials |
| NCT05775874 | A Study to Evaluate the Safety and Efficacy of AZD4547 Combination With Tislelizumab in Patients With mUC | unknown | Phase 2 | 80 | Abbisko Therapeutics Co, LtdINDUSTRY | 1 | Mar 20, 2023 | clinicaltrials |
| NCT05773183 | Exploring the Relationship Between Androgen Metabolism, Metabolic Disease and Skeletal Muscle Energy Balance in Men(MMetdMH) | unknown | — | 60 | Royal College of Surgeons, IrelandOTHER | 1 | Mar 17, 2023 | clinicaltrials |
| NCT01881659 | Cervical Cancer Screening With Human Papillomavirus Testing(ESTAMPA) | unknown | — | 50,000 | International Agency for Research on CancerOTHER | 9 | Mar 14, 2023 | clinicaltrials |
| NCT04565275 | A Study of ICP-192 in Patients With Advanced Solid Tumors | unknown | Phase 1 / Phase 2 | 45 | Beijing InnoCare Pharma Tech Co., Ltd.INDUSTRY | 2 | Mar 14, 2023 | clinicaltrials |
| NCT04724031 | Real World Data Analysis of PARP Inhibitors Use in Patients With Ovarian Cancer | unknown | — | 150 | Hellenic Cooperative Oncology GroupOTHER | 1 | Mar 14, 2023 | clinicaltrials |
| NCT05755893 | Unusual Infiltrative Patterns of Malignant Cells in Endometrial Carcinoma and Immunohistochemical Expression of P53 | unknown | — | 100 | Assiut UniversityOTHER | 0 | Mar 14, 2023 | clinicaltrials |
| NCT05767528 | Clinical Study of Neoadjuvant Therapy Outcome Prediction of Muscle-invasive Bladder Cancer Based on PTC Drug Sensitivity Detection | unknown | — | 40 | Chinese PLA General HospitalOTHER | 1 | Mar 14, 2023 | clinicaltrials |
| NCT05429866 | Immunological Variables Associated to ICI Toxicity in Cancer Patients | unknown | Phase 2 | 441 | Jules Bordet InstituteOTHER | 1 | Mar 8, 2023 | clinicaltrials |
| NCT05184140 | Mapping Sentinel Lymph Node in Initial Stages of Ovarian Cancer(MELISA) | unknown | N/A | 62 | Hospital Clinic of BarcelonaOTHER | 1 | Mar 7, 2023 | clinicaltrials |
| NCT03475953 | A Phase I/II Study of Regorafenib Plus Avelumab in Solid Tumors(REGOMUNE) | unknown | Phase 1 / Phase 2 | 747 | Institut BergoniéOTHER | 1 | Mar 3, 2023 | clinicaltrials |
| NCT04752865 | Effects of Cytotoxic Chemotherapy and PARP Inhibition on the Genomic Contexture of Ovarian Cancer | unknown | — | 50 | Hellenic Cooperative Oncology GroupOTHER | 1 | Mar 1, 2023 | clinicaltrials |
| NCT01968538 | Metabolomic Study for Localized Prostate Cancer | unknown | — | 400 | Georgetown UniversityOTHER | 1 | Feb 28, 2023 | clinicaltrials |
| NCT01766492 | Quality of Life in Patients With Clinically Localized Prostate Cancer Treated With Radiosurgery(PR-PROS) | unknown | — | 200 | Georgetown UniversityOTHER | 1 | Feb 23, 2023 | clinicaltrials |
| NCT05733793 | Molecular Data and Their Correlations With Clinical Outcomes in Gynecological Cancer Patients.(GYNGER) | unknown | — | 300 | National Cancer Institute, NaplesOTHER | 1 | Feb 23, 2023 | clinicaltrials |
| NCT05741671 | Sonographic Features of Fibroids Before and During Non-surgical Therapy and/or Expectant Management(MYOVASC) | unknown | — | 760 | Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)OTHER | 1 | Feb 23, 2023 | clinicaltrials |
| NCT01618851 | Phase II Study to Evaluate Conventional Radiation Therapy Followed by Radiosurgical Boost in Clinically Localized Prostate Cancer | unknown | N/A | 70 | Georgetown UniversityOTHER | 0 | Feb 22, 2023 | clinicaltrials |
| NCT05403190 | The Performance of da Vinci SP System on Extraperitoneal Approach Radical Prostatectomy(CGMH-SPEAR-P) | unknown | N/A | 30 | Chang Gung Memorial HospitalOTHER | 1 | Feb 22, 2023 | clinicaltrials |
| NCT05265117 | The Efficacy of Hyperthermic Intraperitoneal Chemotherapy to Ovarian Cancer Patients With Homologous Recombination Repair Defect and Residual: a Prospective Cohort Study | unknown | — | 310 | Sun Yat-Sen Memorial Hospital of Sun Yat-Sen UniversityOTHER | 1 | Feb 17, 2023 | clinicaltrials |
| NCT05732857 | Valveless Trocar Versus Standard Trocar in Robot-assisted Complex Partial Nephrectomy | unknown | N/A | 66 | Regina Elena Cancer InstituteOTHER | 1 | Feb 17, 2023 | clinicaltrials |
| NCT03756077 | A Study of the Value of Hybrid PET/MR and PET/CT in Prostate Cancer | unknown | — | 100 | Union Hospital, Tongji Medical College, Huazhong University of Science and TechnologyOTHER | 1 | Feb 14, 2023 | clinicaltrials |
| NCT04799847 | Catumaxomab in Patients With Non-Muscle-Invasive Bladder Cancer Who Have Failed or Are Intolerant to BCG Vaccine | unknown | Phase 1 / Phase 2 | 161 | LintonPharm Co.,Ltd.INDUSTRY | 1 | Feb 13, 2023 | clinicaltrials |
| NCT05723991 | Study of Disitamab Vedotin Combined With Gemcitabine in Neoadjuvant Treatment of Urothelial Carcinoma | unknown | Phase 4 | 36 | Chunguang yang (101937)OTHER | 1 | Feb 13, 2023 | clinicaltrials |
| NCT05643807 | Bladder Washing Cytology for Detection of Urothelial Carcinoma Using Catheter or Flexible Cystoscope: Which is Better?(BWash) | unknown | N/A | 414 | Centre Hospitalier Universitaire VaudoisOTHER | 1 | Feb 10, 2023 | clinicaltrials |
| NCT04438564 | Immunoassay and Regulation of Traditional Chinese Medicine on Cancer Patients | unknown | N/A | 300 | China Medical University HospitalOTHER | 1 | Feb 8, 2023 | clinicaltrials |
| NCT05193669 | Clinical Validation of Molecular Triage in HR-HPV Positive Women(VALTRIHP) | unknown | — | 23,941 | Hiantis SrlINDUSTRY | 1 | Feb 8, 2023 | clinicaltrials |
| NCT05717634 | Endometrial Changes in Breast Cancer Women. | unknown | — | 829 | Regina Elena Cancer InstituteOTHER | 1 | Feb 8, 2023 | clinicaltrials |
| NCT03321188 | Heated Intraperitoneal Chemotherapy in Primary Ovarian Cancer Patients | unknown | Phase 2 | 20 | Andrea JewellOTHER | 1 | Feb 6, 2023 | clinicaltrials |
| NCT04689178 | Cervical Cancer Screening Uptake: A Randomised Controlled Trial Assessing the Effect of Sending Invitation Letters to Nonadherent Women(IMPACTGP) | unknown | N/A | 195,000 | Nantes University HospitalOTHER | 1 | Feb 6, 2023 | clinicaltrials |
| NCT05244577 | Olanzapine Combined With Fosaprepitant, Ondansetron, and Dexamethasone for Preventing Nausea and Vomiting in Patients With Testicular Cancer | unknown | Phase 3 | 75 | Shi YanxiaOTHER | 1 | Feb 6, 2023 | clinicaltrials |
| NCT01972867 | Study of NanoKnife for Ablation of Prostate Cancer in Intermediate Risk Patients | unknown | N/A | 6 | Angiodynamics, Inc.INDUSTRY | 1 | Feb 1, 2023 | clinicaltrials |
| NCT05287048 | Evaluation of MCM5 in Postmenopausal Bleeding Patients | unknown | — | 2,000 | Arquer Diagnostics LtdINDUSTRY | 1 | Feb 1, 2023 | clinicaltrials |
| NCT05508568 | A Performance Evaluation Study of Arquer's MCM5 Elisa Test (ADXBLADDER) to Aid in the Monitoring of Recurrence in Non-Muscle Invasive Bladder Cancer | unknown | — | 650 | Arquer Diagnostics LtdINDUSTRY | 1 | Feb 1, 2023 | clinicaltrials |
| NCT05453825 | A Study of Navicixizumab Monotherapy or in Combination in Patients With Select Advanced Solid Tumors | unknown | Phase 2 | 180 | OncXerna Theraputics, Inc.INDUSTRY | 1 | Jan 31, 2023 | clinicaltrials |
| NCT05705583 | A Companion Diagnostic Study to Develop Circulating Exosomes as Predictive Biomarkers for the Response to Immunotherapy in Renal Cell Carcinoma | unknown | — | 100 | Zhejiang Cancer HospitalOTHER | 1 | Jan 31, 2023 | clinicaltrials |
| NCT05707312 | Staging Endometrial caNcer Based on molEcular ClAssification | unknown | — | 1,032 | Clinica Universidad de Navarra, Universidad de NavarraOTHER | 1 | Jan 31, 2023 | clinicaltrials |
| NCT05702619 | Hypoxia-driven Prostate Cancer Genomics (HYPROGEN)(HYPROGEN) | unknown | — | 60 | The Christie NHS Foundation TrustOTHER | 1 | Jan 27, 2023 | clinicaltrials |
| NCT04704908 | Immuno-persistence Study of a Recombinant Human Papillomavirus 16/18 Bivalent Vaccine in Preadolescent Girls (54m) | unknown | — | 979 | Jun ZhangOTHER | 1 | Jan 26, 2023 | clinicaltrials |
| NCT04969445 | The Durability of Protection Study of a Recombinant HPV 16/18 Bivalent Vaccine in Female | unknown | — | 647 | Jun ZhangOTHER | 1 | Jan 26, 2023 | clinicaltrials |
| NCT05045755 | The Durability of Protection and Immuno-persistence Study of a Recombinant HPV 16/18 Bivalent Vaccine in Female | unknown | — | 1,339 | Jun ZhangOTHER | 1 | Jan 26, 2023 | clinicaltrials |
| NCT05700370 | MyProstateScore Equivalency With and Without DRE | unknown | N/A | 800 | LynxDxINDUSTRY | 1 | Jan 26, 2023 | clinicaltrials |
| NCT05697224 | Aschistosoma Haematobiumspecific microRNAas a Tumor Marker for Early Diagnosis and Prognosis of Bilharzial Bladder Cancer in Eygpt | unknown | N/A | 50 | Sohag UniversityOTHER | 0 | Jan 25, 2023 | clinicaltrials |
| NCT05533203 | Safety of Prodencel in the Treatment of Metastatic Castration-resistant Prostate Cancer (mCRPC) | unknown | Phase 1 | 24 | Shanghai Humantech Biotechnology Co. LtdINDUSTRY | 1 | Jan 23, 2023 | clinicaltrials |
| NCT05693974 | Early Detection of Ovarian Cancer Using Plasma Cell-free DNA Fragmentomics (Retrospective Study) | unknown | — | 130 | Sun Yat-Sen Memorial Hospital of Sun Yat-Sen UniversityOTHER | 1 | Jan 23, 2023 | clinicaltrials |
| NCT05693987 | Early Detection of Ovarian Cancer Using Plasma Cell-free DNA Fragmentomics (Prospective Study) | unknown | — | 248 | Sun Yat-Sen Memorial Hospital of Sun Yat-Sen UniversityOTHER | 1 | Jan 23, 2023 | clinicaltrials |
| NCT02759380 | Can Dietary Phytoestrogens Slow Down Prostate Tumor Proliferation?(PRODICA) | unknown | N/A | 240 | Sahlgrenska University HospitalOTHER | 1 | Jan 20, 2023 | clinicaltrials |
| NCT05692102 | Quality of Life After Gynacological Malignancies | unknown | — | 100 | Assiut UniversityOTHER | 0 | Jan 20, 2023 | clinicaltrials |
Data updated 23 days agoSource updated Mar 23, 2023source: clinicaltrials